Rezlod (Dorzolamide) eye drops 2% 5ml Резлод

Rezlod Indications

for monotherapy of patients with increased intraocular pressure, which is contraindicated in the use of beta-blockers, or in the absence of response to therapy with beta-blockers in the treatment:

- intraocular hypertension;

- open-angle glaucoma;

- pseudoexfoliative glaucoma;

- as adjunctive therapy with beta-adrenoceptor blockers.

Contradictions

Hypersensitivity to the active substance or to any of the excipients.

In patients with severe renal impairment (creatinine clearance)

Dosage & Administration

When used as monotherapy, 1 drop of the drug is instilled into the conjunctival sac of the affected eye three times a day.

When used as adjunctive therapy in combination with ophthalmic drugs, beta-blockers instill 1 drop in the conjunctival sac of the affected eye twice a day.

If the drug is prescribed to replace another ophthalmic antiglaucoma drug, the use of the drug Reslod should be started the day after the last use of the previous drug.

When using several topical ophthalmic drugs, they should be instilled at least 10 minutes apart.

Wash your hands before using the drug, and when instilling eye drops, avoid any contact of the dropper tip with the eye or skin.

Patients should be informed of the proper handling of ophthalmic dropper vials.

Patients should also be informed that if mishandled, eye drops can become contaminated with common bacteria that cause infectious eye diseases. The use of contaminated solutions can lead to serious eye damage followed by vision loss.